Screener
Eligibility screening
Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
1 US site in CA
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.